'''Kanabinol''' ('''CBN''') je slab [[Psihoaktivni lek|psihoaktivni]] [[kanabinoid]] prisutan u -{''[[Kanabis|Cannabis sativa]]''}- i -{''[[Kanabis|Cannabis indica]]''}-.<ref name="pmid1221432">{{cite journal |vauthors=Karniol IG, Shirakawa I, Takahashi RN, Knobel E, Musty RE |title=Effects of delta9-tetrahydrocannabinol and cannabinol in man |journal=Pharmacology |volume=13 |issue=6 |pages=502–12 |year=1975 |pmid=1221432 |doi=10.1159/000136944 |url= }}</ref> On je takođe [[metabolit]] [[tetrahidrokanabinol]]a (THC).<ref name="pmid1140243">{{cite journal |vauthors=McCallum ND, Yagen B, Levy S, Mechoulam R |title=Cannabinol: a rapidly formed metabolite of delta-1- and delta-6-tetrahydrocannabinol |journal=Experientia |volume=31 |issue=5 |pages=520–1 |year=1975 |month=May |pmid=1140243 |doi= |url= }}</ref> CBN deluje kao slab [[agonist (farmakologija)|agonist]] [[CB1 receptor]]a. On ima visok afinitet za [[CB2 receptor|CB<sub>2</sub>]] [[Receptor (biohemija)|receptore]], mada niži nego [[THC]].<ref name="pmid11020293">{{cite journal |vauthors=Mahadevan A, Siegel C, Martin BR, Abood ME, Beletskaya I, Razdan RK |title=Novel cannabinol probes for CB1 and CB2 cannabinoid receptors |journal=Journal of Medicinal Chemistry |volume=43 |issue=20 |pages=3778–85 |year=2000 |month=October |pmid=11020293 |doi=10.1021/jm0001572}}</ref><ref name="pmid9667767">{{cite journal |vauthors=Petitet F, Jeantaud B, Reibaud M, Imperato A, Dubroeucq MC |title=Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors |journal=Life Sciences |volume=63 |issue=1 |pages=PL1–6 |year=1998 |pmid=9667767 |doi=10.1016/S0024-3205(98)00238-0 |url=http://linkinghub.elsevier.com/retrieve/pii/S0024320598002380}}</ref>
